ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 84 filers reported holding ATHIRA PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $204,750 | -21.1% | 81,900 | 0.0% | 0.00% | – |
| Q4 2022 | $259,623 | +13.9% | 81,900 | +6.9% | 0.00% | – |
| Q3 2022 | $228,000 | +11.8% | 76,600 | +14.5% | 0.00% | – |
| Q2 2022 | $204,000 | -71.1% | 66,900 | +28.2% | 0.00% | – |
| Q1 2022 | $705,000 | -1.3% | 52,200 | -4.7% | 0.00% | – |
| Q4 2021 | $714,000 | +38.9% | 54,800 | 0.0% | 0.00% | – |
| Q3 2021 | $514,000 | -8.4% | 54,800 | 0.0% | 0.00% | – |
| Q2 2021 | $561,000 | – | 54,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,196,196 | $11,220,000 | 1.44% |
| Logos Global Management LP | 1,855,812 | $17,408,000 | 1.26% |
| ACUTA CAPITAL PARTNERS, LLC | 297,362 | $2,789,000 | 0.98% |
| Bristlecone Advisors, LLC | 761,563 | $7,143,000 | 0.94% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 106,388 | $998,000 | 0.56% |
| Perceptive Advisors | 3,425,916 | $32,135,000 | 0.47% |
| DAFNA Capital Management LLC | 160,983 | $1,510,000 | 0.40% |
| PATHSTONE FAMILY OFFICE, LLC | 1,146,447 | $10,754,000 | 0.31% |
| RTW INVESTMENTS, LP | 1,906,557 | $17,884,000 | 0.27% |
| EMC Capital Management | 26,487 | $346,000 | 0.19% |